Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
2009
|
|
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs)
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
|
2021
|
|
SARS-CoV-2 Assay Development, Training, and Standardization
|
Resource Development
|
FDA
|
NIAID
|
2020
|
|
SARS-CoV-2 Assessment of Viral Evolution Program (SAVE)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NIAID
|
2021
|
|
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)
|
Other
|
CDC, FDA
|
NIAID
|
2020
|
|
Sequencing Quality Control Phase 2 (SEQC2)
|
Resource Development
|
FDA
|
NLM, CIT, NCI, NHLBI, NIEHS
|
2017
|
|
SHIELD Standardization of Lab Data to Enhance Outcomes Research and Value Based Care (SHIELD)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
|
|
Smokefree.gov
|
Resource Development
|
CDC, FDA, IHS
|
NIMHD
|
2003
|
|
Somatic Cell Genome Editing
|
Research Initiative
|
FDA
|
NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ OSC
|
2017
|
|
Standardization of Lab Data to Enhance Outcomes Research and Value Based Care (SHIELD)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
|
|
Steering Committee Meeting for PAR 18-947/PAR 22-049: "Integrating Biospecimen Science Approaches into Clinical Assay Development"
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2020
|
|
Steering Committee of the Scientific Interest Group in Glycobiology
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Stimulating Peripheral Activity to Relieve Conditions (SPARC)
|
Research Initiative
|
FDA
|
NCATS, NCCIH, NCI, NEI, NHLBI, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIMH, NINDS, OD/ DPCPSI/ OSC
|
2016
|
|
STS/ACC TVT Registry
|
Meeting/ Workshop
|
CMS, FDA
|
|
|
|
Subcommittee on Open Science (Formerly Interagency Working Group on Open Science)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, OS
|
NLM, OD/ OER, OD/ OSP
|
2013
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, IOS
|
OD/ OSP
|
2013
|
|
System of Hospitals for Innovation in Pediatrics - Medical Devices (SHIP-MD)
|
Meeting/ Workshop
|
FDA
|
NICHD
|
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA
|
|
2003
|
|
|